Major 10% Shareholder Files Intent to Sell Additional $596K in Shares
TNYA sits 69% above its 52-week low of $0.36.
Summary
COLUMN GROUP III-A, LP, a 10% stockholder, has filed another Form 144 indicating intent to sell approximately $596,552 worth of common stock, continuing a pattern of distribution.
Key Events · Ownership and Investor Activity · TNYA
-
Intent to Sell Additional Shares
COLUMN GROUP III-A, LP, a 10% stockholder, filed a Form 144 to sell 1,060,727 shares of common stock, valued at approximately $596,552.86.
-
Continued Shareholder Distribution
This filing is part of an ongoing pattern of sales from this 10% owner, following a previous Form 144 filed on February 20, 2026, for $985,362.
-
Significant Insider Selling Trend
The proposed sale contributes to a broader trend of insider distribution, with net insider sales totaling over $3.5 million in the last 90 days.
Analysis · TNYA · Life Sciences
This Form 144 filing from COLUMN GROUP III-A, LP signals continued selling pressure from a significant institutional investor. This follows previous Form 144 filings from the same entity, including one on February 20, 2026, for $985,362. The proposed sale of over half a million dollars in shares, representing approximately 0.46% of the company's market capitalization, adds to the ongoing distribution trend observed over the past 90 days, where net insider sales total over $3.5 million. Investors should note the persistent intent of this major shareholder to reduce its stake.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TNYA was trading at $0.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $130.3M. The 52-week trading range was $0.36 to $2.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.